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TUMOR DISSEMINATION AFTER THORACOSCOPIC RESECTION FOR LUNG CANCER 
J. Buhr, MD, M. Hürtgen, MD, C. Kelm, MD, and K. Schwemmle, MD, Giessen, Germany 
Many peripheral nodules of the lung that cannot be 
determined to be benign by means of radiographic assess- 
ment require resection to rule out malignancy. The rapid 
evolution of minimally invasive surgical techniques is 
stimulating new technical and surgical innovations. Grow- 
ing enthusiasm for these minimally invasive surgical pro- 
cedures has led to an expanded role for thoracoscopic or
video-assisted thoracic surgery for the solution of many 
intrathoracic surgical problems. Thoracoscopic surgery 
has expanded from a rarely used technique for the eval- 
uation of benign diseases to an operative approach used in 
the treatement of lung cancer. At this writing, there have 
been reports of nearly 100 thoracoscopic orvideo-assisted 
resections in ~Lhe treatment of lung cancer. 1" 2 
In January 1990, we began to perform thoracoscopic 
operations in our Department for General and Thoracic 
Surgery in Giessen, Germany. Since January 1992, we 
have elected a thoracoscopic approach for some nodules 
of the lung because of our good experiences with thora- 
coscopic wedge resection for such benign diseases as 
pneumothorax. 
Although the decrease in postoperative pain is obvious 
in the early period after operation, 3 there remains con- 
cern about oncologic aspects of this approach. We there- 
lore report on two cases of tumor dissemination after 
thoracoscopic resection for lung cancer. 
In 63 cases, nodules were resected by thoracoscopic 
wedge resection. In 21 cases, malignancy was demon- 
strated (14 metastases and seven primary lung cancers). In 
two of these patients, tumor cell dissemination was ob- 
served. 
Case 1. In July 1992, we treated a patient who had bad 
lung function and a peripheral nodule (1.5 cm diameter 
on computed tomographic s an) of the right upper lobe by 
means of thoracoscopic wedge resection. The histologic 
examination showed an adenocarcinoma without infiltra- 
tion of the pleura visceralis (pathologic lassification Tl, 
grade 2). By means of intraoperative pleural lavage, we 
found tumor cells remaining after the thoracoscopic re- 
section. In February 1994, we detected a metastatic nod- 
ule (3 cm in diameter) at the site in the chest wall where 
the tumor was extracted uring the thoracoscopic opera- 
tion. On computed tomographic s an, we did not find any 
tumor recurrence in the lung. We performed a curative 
resection of the tumor located at the thoracic wall. One 
year after the operation, the patient was in good condition 
and remained free of any other tumor manifestations. 
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Case 2. A thoracoscopic wedge resection of a periph- 
eral tumor (2 cm diameter on computed tomographic 
scan) of a patient's right upper lobe was performed in 
January 1993. The histologic examination of the frozen 
section showed a close resection of an adenocarcinoma 
(only 3 mm distance between tumor and resection). We 
converted the operation to an open lobectomy and per- 
formed additional lymph node dissection. The histologic 
examination of the formalin-fixed tumor showed an ade- 
nocarcinoma with infiltration of the pleural visceralis. The 
final tumor stage was pathologic lassification T2 NO, 
grade 2. The result of pleural avage cytologic examination 
was positive after the thoracoscopic resection. Pleural 
carcinosis, proved by histologic and cytologic examination, 
developed in this patient 6 months after the operation. 
The patient died 14 months after the operation. 
Discussion. In our department, we perform thoraco- 
scopic resection only for peripheral lung tumors smaller 
than 2 cm and in patients with compromised pulmonary 
reserves. All other patients were treated with open lung 
operations. In 46 cases, nodules of the lung were resected 
by thoracoscopic approach. If frozen sections indicated 
malignancy of the nodule, we converted to open lobec- 
tomy and performed formal lymph hode dissection. Be- 
lore and after thoracoscopic resection of the tumor, 
pleural lavage was performed for cytologic examination. 
This procedure should detect tumor cell spread before 
clinical manifestation. We also perform pleural avage in 
open operations for lung cancer. 4 
These two case reports provide a warning for everyone 
who performs or tries to perform thoracoscopic opera- 
tions for patients with from lung cancer. Thoracoscopic 
surgical methods are not able to adjust adequately to the 
specific growth pattern and paths of metastatic spread of 
lung cancer. The loss of palpation and the insufficiency of 
complete mediastinal lymph node dissection are respon- 
sible for the uncertain value of the new method for 
curative oncologic therapy. It is irresponsible to risk the 
internationally quite homogenous tage-related results 
currently obtained in the treatment of lung cancer for the 
sake of pursuing new technical methods. »'6 It is not our 
duty to create a new disease, such as tumor metastasis at 
the extraction site after thoracoscopic resection of lung 
cancer. Thoracoscopic resection for potentially malignant 
diseases hould be restricted to superficial lesions smaller 
than 2 cm. If the medical history or the thoracoscopic 
aspect suggests primary lung cancer, conversion to an 
open procedure is absolutely necessary. 
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TRANSVENTRICULAR MITRAL VALVE DILATOR: AN IMPROVED DESIGN CONCEPT 
Ajay Kaul, MCH, Susmit Bhattacharya, MS, Shirish Borker, MS, A. M. Patwardhan, MS, MS, 
A. P. Chaukar, MB, MS, and A. D. Abhyankar, MD, DM, Bombay, India 
The concept of dilatation of stenotic valves was first put 
forward by Samways in 1898. The Tubbs Logan dilator 
(M/s All lndia Surgical Manufacturing Co., Bombay, 
India) came into use in the 1950s to allow the surgeon to 
treat rheumatic mitral stenosis rauch more easily. 
The advent of sophisticated catheterization laboratory 
techniques and the development of a percutaneous bal- 
loon mitral valve dilator minimized the surgical trauma of 
treatment of mitral stenosis. The balloon mitral valve 
dilator, whether of the Inoue (Toray Industries, Inc., 
Tokyo, Japan) or Mansfield type, is an adequate mitral 
valve dilator as shown by several authors. 1-5 A study by 
Patel and associates 6 concluded that the balloon was a 
superior dilator compared with the Tubbs dilator, whereas 
another study showed similar results with both. 7 
In our hospital percutaneous balloon mitral valvulo- 
plasty and transventricular closed mitral valvotomy are 
performed regularly. We have observed that the gradients 
across the mitral valve fall to 3 to 5 mm Hg after balloon 
dilatation but remain between 7 and 10 mm Hg after a 
Tubbs dilatation. However, these values occurred in dif- 
ferent sets of patients under different conditions and it 
was difficult o arrive at a conclusion regarding efficacy of 
each of the dilators. 
We therefore wanted to do a comparative study in the 
same set of patients under the same conditions. We 
introduced the Inoue balloon dilator through the trans- 
ventricular oute and positioned the balloon across the 
mitral valve with a finger in the left atrium exactly as we do 
with the Tubbs dilator. Inflation was done by an assistant. 
Twelve patients with mitral stenosis were chosen at 
random (Table I). The echocardiographic findings in 
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Table I. Data on 12 patients with mitral stenosis 
chosen for study 
Men 5 
Women 7 
Age (yr) 18-44 
Mean age (yr) 24 
Height (cm) 130-177 
Mean height (cm) 162.4 
No. in NYHA class II 4 
No. in NYH class III 8 
NYHA, New York Heart Association. 
Table I I .  Echocardiographic evaluation 
MVA (cm 2) 0.6-1.3 
Gradient aeross mitral valve 13-36 
(mm Hg) 
Mean gradient across 21.43 +_ 7.87 
mitral valve (mm Hg) 




Grade I mitral regurgitation 
Atrial fibrillation 
Moderate to severe 
crowding 
Nil in 8 patients; 
minimal in 4 patients 
2 patients 
1 patient; no LA clots 
on TEE 
MVA, Mitral valve area; LA, left atrial. 
these patients are summarized in Table II. They were 
divided into two groups. In group I (n = 5), valves were 
first dilated with a balloon introduced through the left 
ventricle. After complete dilatation we tried using a Tubbs 
dilator to see whether there were any changes. In group II 
(n = 7) the sequence was reversed. The maximum dilata- 
